HSE X Accelerator
AcceleratorSeed
Find your way into HSE X Accelerator
Sign up to see every warm intro you have to HSE X Accelerator
- Paths you didn't know you had: your email and LinkedIn already hold routes to the HSE X Accelerator team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Investment thesis
HSE X Accelerator is a startup accelerator program that runs a cohort-based application and program cycle, culminating in demo days (HSE Fest and X Business Club) and offering post-graduation support.
Source: firm website, verified Aug 3, 2026.
Frequently asked questions
- What stage does HSE X Accelerator invest at?
- HSE X Accelerator invests at the Seed stage.
- What sectors does HSE X Accelerator focus on?
- HSE X Accelerator focuses on B2B Marketplaces.
Images
Similar investors
Amadeus Capital Partners is a UK-based deep tech venture capital firm founded in 1997 that invests in technology companies from seed to growth stage. Since inception it has backed over 200 companies and raised more than $1.3 billion.
Bessemer Venture Partners is a global venture capital firm that partners with entrepreneurs across enterprise, consumer, and healthcare sectors from early stages through growth.
DCM Ventures is an early-stage venture capital firm that leads rounds and partners with a small number of companies each year, backing innovative founders with a global, cross-border team.
Dot Capital is a boutique New York City venture capital firm founded in 2012 that invests in disruptive growth technology companies across sectors like SaaS, mobile, digital media, IoT and internet infrastructure.
FJ Labs is an early-stage investment firm specializing in marketplaces and network-effect businesses, taking an angel-style co-investment approach alongside institutional venture funds worldwide.




